Australian Commentary to the US DHHS Guidelines for the use of Antiretroviral Agents in Adults and Adolescents with HIV

US DHHS Guidelines with Australian Commentary

Table of Contents

Study and Trial Names

DHHS Last Updated: March 2023Australian Commentary Last Updated: July 2023

Acronym/Abbreviation Name
ACTG AIDS Clinical Trials Group
ADVANCE Assessing Donor Variability And New Concepts in Eligibility
ARDENT ACTG A5257 trial
ARTEMIS Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
ATLAS Antiretroviral Therapy as Long-Acting Suppression
D:A:D Data Collection on Adverse Events of Anti-HIV Drugs
ECHO Evidence for Contraceptive Options in HIV
ENCORE Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
FLAIR First Long-Acting Injectable Regimen
FLAMINGO Dolutegravir Compared to Darunavir/Ritonavir, Each in Combination With Dual Nucleoside ReverseTranscriptase Inhibitors
HPTN HIV Prevention Trials Network
NADIA Nucleosides And Darunavir/Dolutegravir In Africa
NAMSAL New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries
STaR Single-Tablet Regimen
START Strategic Timing of AntiRetroviral Trea
Scroll to Top